UK Telemedicine Market Outlook to 2022 – Ken Research

The report titled “UK Telemedicine Market Outlook to 2022 - by Services (Tele Home & M-Health and Tele Hospital), by Technology Platform (Software, Hardware and Telecom), by Clinical Applications (Tele Cancer Services, Tele Radiology, Tele Pathology, Tele Neurology, Tele Psychology and Others)” provides a comprehensive analysis on the UK telemedicine services and technology platform Market. The report covers introduction and genesis, market size, market segmentation by service platforms (Tele Home & M-Health and Tele Hospital), by type of technology platform (Software, Hardware and Telecom), by type of clinical applications (Tele Cancer Services, Tele Radiology, Tele Pathology, Tele Neurology, Tele Psychology and Others) and by delivery mode (Cloud Based and Web Based). The report also covers the overall competitive landscape of major Telemedicine companies including Immedicare, Babylon Health, Push Doctor, Tele Medicine Clinic, Doctor Care Anywhere, Toothpick, Home Touch, Zesty, Skin Analytics, Capture Proof, Medio.Link, Tunstall, Tynetec Ltd., Just Checking, Tele Support. The report also covers Value Chain Analysis in UK telemedicine market, Government regulations, Case Study on successful telemedicine service provider, PEST analysis, along with analyst recommendation and macroeconomic variables.

The report is useful for telemedicine service providers, investors, telemedicine software & hardware companies, potential entrants and other stakeholders to align their market centric strategies according to ongoing and expected trends in the future.

UK Telemedicine Market Size and Overview

Market Size: Telemedicine market in UK is at its growing stage. A number of Telemedicine devices are emerging such as blood pressure monitoring, weight management machines, interactive stethoscope, ENT otoscope and general examination camera. Increasing government funding and grants for telemedicine, consistent need for improved healthcare quality services and increasing number of smart phone users has boosted the telemedicine market. Telemedicine technology has been expanding with integrated home-healthcare connected at telemedicine platforms. In 2017, the UK’s NHS launched a new service where patients can speak to a physician through their mobile devices via video call or text. The service called GP At Hand is available countrywide and as is the case with most NHS services, is free at the point of delivery.

Market Segmentation:

By Service and Technology Platform

In 2017, service platform has dominated the UK telemedicine market. Services has higher market share. Technology involves onetime cost and services upgrade from time to time. Moreover, a person will at least consult a GP, doctor or a nurse twice for a particular disease. The technology platform consists of software, hardware and telecom out of which software has dominated the market.

By Type of Service Platform

In 2017, Tele home and M-health services has dominated the UK Telemedicine market followed by Tele hospital. Aging population, increase in diabetic and cancer patients, less number of clinics, growing need for remote patient monitoring services, ease in consultation process and less consultation fee in comparison to hospital visit are the main growth drivers which have propelled the growth of Tele home and M-Health services.

By Type of Technology Platform

In 2017, software services have contributed the highest share in terms of revenue in UK telemedicine market. The software leads in the market because software requires up gradation with time in order to add more features and for fixing up the bugs. This adds cost to software maintenance. The hardware services hold the second highest share followed by telecom having share contribution in 2017. Telemedicine hardware is used to render healthcare services from a distance or remote locations. With the increase in the demand of digital health platform, the demand for telemedicine hardware is also increasing.

By Clinical Applications

In 2017, Tele cancer services have dominated the market in terms of domestic revenue. Tele cancer services dominate because of the rising number of cancer cases in the country. In 2017, the Tele Radiology contributed the second highest share followed by Tele Pathology, Tele Neurology, Tele Psychology services. Others services include dermatology, epidemiology, prescription counseling, surgical applications, cardiology and dentistry has contributed the least share in UK Telemedicine market in 2017.

By Delivery Mode

In 2017, cloud base delivery mode has dominated the market followed by web based services. In cloud based the telemedicine company uploads the patient’s documents, prescriptions and X-rays on the cloud server from where doctors can access the documents any time they want through their personal device. The web based services are less expensive in comparison to cloud based services as in web based just LAN connection is required and low storage hard drives.

Competitive Landscape

UK Tele Medicine market is highly concentrated with the presence of around 40-45 players in the market. The entry barriers are high for a company entering into the Tele Medicine market. The set up cost of Tele Medicine business is also very high as it requires latest technology equipments with most modern services for providing best results and consultation to the patient either through video or audio system. The leading companies in UK Telemedicine market are Immedicare, Medio.Link, Babylon Health, Push Doctor, Tele Medicine Clinic, Medio.Link, Doctor Care Anywhere, Toothpick, Home Touch, Zesty, Skin Analytics, Capture Proof, Tunstall, Tynetec Ltd., Just Checking, Tele Support and others. Telemedicine players are concentrated on improving their technology offerings in terms of hardware, network and software (i.e., enabling technologies), experience in the market, services offered, cost of services, range of medical applications offered and others. Healthcare companies are evaluating the return on investment (ROI) and clinical consequences of the telemedicine technology. Some of the leading telehealth companies are Care Innovation, Doro Care, Living Safely, Tele health Solutions, Appello, Tec Angel, Tunstall and Tynetec.

Future Outlook to UK Telemedicine Market

UK Telemedicine market is expected to increase at a double digit CAGR in between the year 2018 and 2022 in terms of revenue due to the increasing number of aging population, growing number of smart phone users and rising healthcare cost. The demand for telemedicine in UK is expected to grow at a rapid pace from 2021 to 2022. The growth will be driven by the increasing emphasis of healthcare information technology (HIT) players, increasing prevalence of chronic diseases and continual investments from both public and private sectors. Since radiology has proven to be such an effective field for outsourcing via telemedicine, many hospitals will be looking at the possibility of splitting off many other specializations. Psychiatry, neurology, and many other disciplines are ripe for decentralization employing Tele health practices.

Key Topics Covered in the Report:-

·         UK Telemedicine market overview and genesis

·         Value chain analysis in UK Telemedicine Market

·         UK Telemedicine market size

·         UK Telemedicine market segmentation by service and technology platform, by type of service platform (Tele Home & M-Health and Tele Hospital), by type of technology platform (Software, Hardware and Telecom), by type of clinical applications (Tele Cancer Services, Tele Radiology, Tele Pathology, Tele Neurology, Tele Psychology and Others) and by delivery mode (Cloud Based and Web Based)

·         Trends and Development in UK Telemedicine Market

·         Issues and Challenges in UK Telemedicine Market

·         Case Study on successful telemedicine service provider

·         Government regulation in UK Telemedicine market

·         PEST Analysis in UK Telemedicine market

·         Competitive landscape in UK Telemedicine market

·         Company profiling for major players in UK Telemedicine market

·         Telemedicine software companies

·         Telemedicine hardware companies

·         UK Telemedicine market future outlook and projections

·         Analyst Recommendations

·         Macroeconomic Factors in UK Telemedicine market

For More Information, Refer to the Link below:

https://www.kenresearch.com/healthcare/general-healthcare/uk-telemedicine-market/152428-91.html

Related Reports:

https://www.kenresearch.com/healthcare/general-healthcare/global-telemedicine-market-forecast/142618-91.html

https://www.kenresearch.com/healthcare/general-healthcare/us-telemedicine-market-research-report/531-91.html

https://www.kenresearch.com/healthcare/general-healthcare/africa-ehealth-market-research-report/77813-91.html

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
Sales@kenresearch.com
+91-9015378249

Developments In The Global Magnet Bearing Market: Ken Research

According to the study, ‘GLOBAL MAGNET BEARING MARKET RESEARCH REPORT: FORECAST TO 2023’, major players in the magnetic manufacturing market are Calnetix Technologies (U.S.), Siemens AG (Germany), Waukesha Bearings Corporation (U.S.), Mecos AG (Switzerland), Foshan Genesis (China), Synchrony (U.S.), SKF AB (Sweden), Celeroton AG (Switzerland), Schaffer AG (Germany)

In the age of environmental consciousness, companies operating across different industries are trying to build and use machines that have no negative consequences on the environment. In a fit to achieve this objective, companies are rediscovering fundamental principles of physics –magnetic bearings. Magnetic bearings have multiple benefits and these include reduced friction, minimized vibration and enhanced reliability plus the ability to monitor and diagnose. All these are present without the disadvantages associated with lubricants. The basic principle behind magnetic bearing is magnetic levitation that is used to support heavy loads. There are various types of magnetic bearings. One of them is passive magnetic bearings which do not require any power source but are relatively difficult to design when compared to active magnetic bearings which require a control system to monitor the load as well as a continuous power source. One of the key drivers is of the magnetic bearing industry is their increasing use in aerospace and defense industry because of the cost efficiency these magnetic bearings possess.

There have been many developments in the magnetic bearing market. Traditionally, the magnetic bearings were very expensive but due to manufacturing advances that involved integration and standardization of the bearings in the device, the overall cost has reduced significantly. The engineering effort has also been greatly reduced. All these factors have resulted in the magnetic bearings to become more economical. Recent developments have resulted in the overall reduction in the physical size of the bearing by nearly one third. Increasing the amount of steel in the bore whilst simultaneously reducing the steel in the overall body has greatly completed in achieving a reduced size. The length of the radial magnetic bearing has also been reduced. The magnetic bearing also consists of a controller the original size of which was that equal to a refrigerator. However, with recent trends and developments this size now has been reduced to that of a Laptop. Recent technology has allowed the remote to be integrated along with the bearing itself which eliminates the need for a separate remote. On the basis of speed, the market is classified into three segments. These include up to 50,000 RPM, 50,000 RPM to 100,000 RPM and 100,000 RPM & above. The market is dominated by bearings having a maximum speed of 50,000 RPM which are used many end users for multiple uses. Speaking in terms of geography, Asia – Pacific is expected to show the highest growth rate because of number of humongous construction projects and increasing foreign investments in the region.

With the advancements in technology, magnetic bearings today offer got a greater number of machines and applications. Innovations related to design that relate to miniaturization, standardization and integration have resulted in greater usage of magnetic bearings for many existing and new machinery products. The growth in this sector would also be complemented by rising concerns over environmental degradation.

To know more, click on the link below:

https://www.kenresearch.com/manufacturing-and-construction/machinery-and-parts/global-magnet-bearing/151498-97.html

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
sales@kenresearch.com

+91-9015378249

Advancements In Car T-Cells To Better Tackle Peripheral T-Cell Lymphomas Market Outlook: Ken Research

According to the study, ‘PERIPHERAL T-CELL LYMPHOMAS (PTCL) GLOBAL CLINICAL TRIALS REVIEW, H1, 2018’, cancer treatment around the world is improving rapidly and lymphatic cancer is no exception despite the exact causes of peripheral T-cell lymphoma being currently unknown. However, the cancer is believed to be associated with the exposure to viruses such as the human T-cell leukemia virus-1 (HTLV-1). Presently available treatment includes chemotherapy, localized radiotherapy, stem cell transplants and steroid therapy. New treatment options are also being explored and experimented. Understanding the causes of PTCL has been a major contributor to this new development.    

Lymphoma is a cancer of the lymphatic system which affects a type of white blood cell known as lymphocytes that help fight diseases in the body.    T-cell is a type of white blood cell that is of key importance to the immune system that triggers the body’s response to certain pathogens. A similar lymphocyte called Natural Killer (NK) cell shares many features with T-cells. When NK cells become cancerous, the cancer is called NK or T-cell lymphoma and develops in lymphoid tissue such as the lymph nodes and spleen. Peripheral T-cell lymphoma (PTCL) is defined as a diverse group of aggressive lymphomas that develop from mature stage white blood cells called T-cells and NK cells.

In May 2018, the American Society of Clinical Oncology (ASCO) announced chimeric antigen receptor (CAR) T-cell therapy as Advance of The Year for 2018. CAR T-cell therapy is a type of treatment in which a patient’s T-cells are changed in the laboratory such that they will attack cancer cells. T-cells are taken from a patient’s blood and then the gene for a special receptor that binds to the CD-19 protein on the cancer cells is added in the laboratory.  This special receptor is called CAR. Large numbers of CAR T-cells are grown in the laboratory and are given to the patient by infusion.

In 2017 also there were major triumphs for this technology as the year saw some major developments regarding the same. Two CAR T-cell therapies were approved by the US FDA, one for the treatment of children with acute lymphoblastic leukemia and the other for adults with advanced lymphomas. These clinical successes are part of a rapidly emerging immunotherapy approach which is called adoptive cell transfer (ACT) which is collecting and altering the patient’s own immune cells to treat their cancer. There are several types of ACT but the one that has advanced the furthest in clinical development is CAR T-cell therapy.

 This approach is currently being seen as a means to transform cancer care as it represents an exciting innovation. CAR T-cell therapy is clinically the most advanced of the adoptive cell transfer (ACT) class of immunotherapy and has primarily been used in patients with advanced blood cancer. Nevertheless, researchers are still developing the field of ACT in order to expand their effectiveness against solid tumors such as breast and colorectal cancer. Immunotherapy is continuously innovating and developments like CAR T-cells cement this fact with present operative capacity in lymphatic sectors. Many more CAR T-cell clinical trials are currently underway and further substantial progress is expected in the next few years.

To know more, click on the link below:

https://www.kenresearch.com/healthcare/general-healthcare/peripheral-t-cell-lymphomas/150994-91.html

Related Reports

https://www.kenresearch.com/healthcare/pharmaceuticals/peripheral-t-cell-lymphomas-ptcl-global-clinical-trials-review-h2-2016/54153-91.html

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
sales@kenresearch.com

+91-9015378249

R&D On Electro-Refining To Boost Copper Cathode Market in Asia: Ken Research

Copper is an essential mineral, element, and a major industrial metal because of its high ductility, malleability, thermal conductivity, electrical conductivity and resistance to corrosion. Copper is found in form of ore in many parts of the world, however, small amounts of copper are occasionally found in distorted cubic crystal chunks. Copper metal is also recognized as the center of technological advancements with its wide range of applications. It is used in the production of brass, copper sheet products, copper tubes and is used in manufacture of more than 450 alloys. Copper cathode is manufactured using copper with purity of more than 95%. Copper is the chief raw material used in the production of copper rod, which is utilized in several industries for various production processes due to its excellent electrical conductivity.

According to the study “Asia Copper Cathode Industry Situation and Prospects Research Report”, copper cathode is manufactured through the refining process, which removes the impurities from copper ore. Asia copper cathode market is segmented based on refining processes such as smelting and electro-refining. Extracting pure form of copper from its ore is termed as smelting. This process uses heat and chemical reducing agent for decomposition of copper ore, elimination of unwanted slag, and other elements to obtaining pure copper cathode. Refining copper ore in the presence of using aqueous solution for extracting pure form of copper cathode at its maximum is termed as electro-refining. Copper cathode is used in oil industry, gas industry, chemical labs, and various other industries such as power generation, telecommunications, electronic circuits, power transmission, and various types of electrical equipment. Copper cathode is a good conductor of electricity and possesses good resistance characteristics. 

Research is carried out in electro-refining process to reduce cost and to recover valuable impurities such as gold, silver, and nickel. Geographically, Asia copper cathode industry is spread across China, India, Japan, Korea, Saudi Arabia and other regions. Various products types in Asia’s copper cathode market are standard quality level and high quality level. Copper cathode is used in manufacturing of conductors, electronic products and in other industries. The leading players in Asia cooper cathode market are Jiangxi Copper Company, Tongling, JX holdings, Sumitomo and BHP Bill. All the leading vendors in Asia’s copper cathode industry are increasingly investing on research to manufacture more long-term reliable copper cathodes.

Major drawbacks in Asia’s copper cathode market are poor resistance to abrasion, common acids and low tensile strength. The capital investment for electro-refining process in copper cathode industry is very high and has shorter life expectancy. Copper cathode possesses high ductility properties compared to other metals with the exception of silver and gold. The market for copper cathode industry in Asia is extensive due to rapid urbanization, industrialization and to develop its existing infrastructure. The market is increasing drastically due to developing efficient and economical smart cities in Asia. This trend will continue over the next few years due to increased consumption in Asian economies.

To know more, click on the link below:

https://www.kenresearch.com/metal-mining-and-chemicals/chemicals/asia-copper-cathode-industry-situation-and-prospects-research-report/145756-101.html

Related Reports:

https://www.kenresearch.com/metal-mining-and-chemicals/chemicals/china-copper-cathode-industry-situation-and-prospects-research-report/146266-101.html

https://www.kenresearch.com/metal-mining-and-chemicals/chemicals/global-copper-cathode-industry-situation-and-prospects-research-report/146098-101.html

Contact Us:

Ken Research

Ankur Gupta, Head Marketing & Communications

sales@kenresearch.com

0124-4230204

Asia Construction Repaint Market Leading Players - Ken Research

Kabbage, Disrupting The Loan Industry For Smes: Ken Research

According to the study, ‘Fintech Profile: Kabbage’, major Kabbage has partnered with SoftBank, Santander, Scotiabank, ING Group, Thomvest Ventures.

Kabbage is an Atlanta based financial technology firm. The company aims to provide direct funding to small businesses and even consumers via an automated funding distribution platform. Rob Frohwein, Marc Gorlin, and Kathryn Petralia were the founders of Kabbage Inc., which was set up in 2009 but began operation in 2011. To qualify for a small business loan, Kabbage has set certain revenue criteria to make it eligible. The minimum revenue that a business should have is USD 50,000 per annum or USD 4,200 per month for the last three months.

Kabbage follows a simple process of dispersing funds to the small and medium enterprises.  They initially make sure that the whether the business is eligible for loan or not. Followed by dispersion of funds and later, the business can easily use this fund to make payments. Kabbage functions primarily in two areas of business and these are small business loans and invoice payments. The small business loans allow very small firms to obtain loan and expand their business without being restricted by limitations as sent by traditional loan providers. The small business loan allows business people to maintain control over their business. For instance if a firm decides to expand by going public or calling aboard a potential investor, the profits and decision making authority shall have to be shared with all the partners. Another benefit small business loans provide is that, the business does not have to undergo a rigorous qualification process. It prevents mixing of personal and business relation if a loan is taken from a personal contact.

Mixing personal and business funds can create problems down the line which can be prevented by small business loans. Kabbage also allows business people to line up to an amount of USD 250,000 that can be used by them for their working capital requirement as and when it is needed. The key USP of Kabbage lies in its ability to process loans for small companies quickly by assessing their creditworthiness using proprietary technology which functions on customer data. The data is analyzed within minutes, an interest rate is set and the funds are dispersed. Another key feature of Kabbage is that the loan application form can be processed via an Android or an Apple phone within minutes without involving any cost. Alongside this, business can link multiple payment options of eBay, PayPal to that allows Kabbage to analyze and give proper loan guidance. Not only this, Kabbage does not try to overload a business with funds but allows technology to decide on the amount of funding that is essential for the business.

In early 2017, Kabbage raised funds from Softbank to expand its operations and to improve on its technology followed by funding from Credit Suisse which primarily focused on improving the application of its Artificial Intelligence technology. Kabbage taps on small and medium enterprise segment that has been ignored by large banks due to their strict policy grant loan. The growth potential in this segment is immense and Kabbage is expected to register high growth in the coming years.

For More Information, Refer to the Link below:-

https://www.kenresearch.com/banking-financial-services-and-insurance/financial-services/fintech-profile-kabbage/149651-93.html

Related Reports:

https://www.kenresearch.com/banking-financial-services-and-insurance/financial-services/fintech-profile-neos/149650-93.html

https://www.kenresearch.com/banking-financial-services-and-insurance/financial-services/fintech-profile-commonbond/149291-93.html

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
Sales@kenresearch.com
+91-9015378249

Understanding the Global XLPE Cable Market Outlook: Ken Research

XLPE is an abbreviation used for cross linking polyethylene cables which have high grade insulation properties and has shown excellent electric conductor characteristics. Since power cables are more prone to hazards and susceptible to damage, they require more attention and care while manufacturing these cables. XLPE are primarily used for power distribution and transmission. The manufacturing of these cables include variety of materials such as Polyvinyl chloride, polyethene, polyurethane, nylon, ethylene propylene diene monomer, thermoplastic elastomers, and many others. XLPE are considered to be ideal to be used as insulating material due to its ability to hold high capacity of short circuit current. XLPE have gained huge significance in large transmission networks due to the stability these cables offer.

The current electricity generation in the world is witnessing an upward trend especially from renewable energy sources however, since the electricity generation points are very far from the areas of consumption for instance residential or industrial areas. Hence transportation of this electricity that is generated requires the use of XLPE cables.  This point is particularly applicable in terms of renewable energy sources because the production houses are very far (Solar farms, Wind mill farms). This is one of the key drivers for XLPE cable market.  As the world is shifting from non renewable to renewable forms of energy development hence more demand of these cables not only because of its capacity to hold high amount of current but also because the transmission loss in these cables is quite less. Other advantage of XLPE cables include that these cables can operate in harsh weather conditions. This makes them all the more suitable for long distance transmission.

According to the study, ‘GLOBAL XLPE CABLE MARKET RESEARCH REPORT: FORECAST TO 2023’, some major companies manufacturing XLPE cables include Brugg Kabel AG (Switzerland), Sumitomo Electric Industries Ltd.(Japan), ABB Ltd (Switzerland), The Prysmian Group (Italy),  General Cable Corporation (U.S.), Nexans S.A.( France), Encore Wire Corporation (U.S.), NKT A/S (Denmark), Finolex Cables Ltd (India), Relemac Technologies Pvt. Ltd (India), Laser Power & Infra Pvt. Ltd (India), KEI Industries Limited (India), Universal Cables Ltd.(India) and Eland Cables (U.K.).

The basic segmentation that is prevalent in the global XLPE cable market is on the basis of area of usage. This includes overhead, underground and underwater cables. Among these the highest share is grabbed by underground cables due to their limited exposure to accidents and lower amount of current dispersion. However, other segmentations in the industry is on the basis of voltage and this includes high medium and low voltage with low voltage holding the highest share because of greater demand from smaller establishments. The market is also divided on the basis of end user application and this includes power, oil & gas, chemical, manufacturing, metals & mining, infrastructure & transportation, and others. Since all these industrial sectors require power, it naturally explains its highest share in this segment. Geographically, U.S. is the market leader for the production of XLPE cables.

Global XLPE market is expected to grow at a very fast rate due to increasing usage on non renewable sources to produce electricity. The competition in this industry is highly fragmented and new companies need to innovate and invest greater amount in the R&D in order to compete with the existing companies.

For More Information, Refer to the Link below:

https://www.kenresearch.com/manufacturing-and-construction/machinery-and-parts/global-xlpe-cable/151497-97.html

Contact Us:

Ken Research 

Ankur Gupta, Head Marketing & Communications

sales@kenresearch.com

+91-9015378249

Asian Economies Encouraging Bio-based Construction Repaints in Paints Market: Ken Research

Construction repaint usually refers to the paint used in homes, multi-family residential, commercial, and institutional applications. Various types of paints are varnishes, emulsions, and enamels which serve the purpose of maintenance, repairs, and renovation work. The introduction of bio-based materials in paints is the major factor affecting the growth of construction repaints market in Asia. Paints and coatings industry has been under subjected to immense pressure from regulatory authorities to reduce the environmental impact of paints. It was observed that renewable raw materials are used in the manufacture of bio-based paints. They are more reliable and sufficient to meet the needs of the increasing population and its expectations. Construction bio-based repaints are used extensively which has witnessed less environmental impact. Major ingredients in construction bio-based repaints are natural oils, resins, waxes, gums, and polysaccharides that provide better carbon performance, life-cycle performance, greater purity, enhanced water solubility, and reduced toxicity.

According to the study “Asia Construction Repaint Industry Situation and Prospects Research Report”, the leading vendors in the Asia construction repaints market are Arkema, Solvay, Nuplex Industries Limited, BASF, Covestro, DIC Corporation, DSM Coating Resins, Momentive Performance Materials, Huntsman, Dow, LyondellBasell Industries and Eastman. Various products in Asia construction repaints market are alkyd, polyurethane, polyester, epoxy, acrylic and others. Acrylic type of repaints category accounted for the major shares of the construction repaints market because they are inexpensive and can be used architectural coatings, product finishes. They are also used by automobile original equipment manufacturers for refinish and special-purpose coatings that will surely contribute to the growth of the construction paints industry. The Asia construction repaints market is categorized based on formulations such as waterborne paints, solvent-borne paints, and power coatings. Waterborne paints segment accounts for a major share in the construction repaints market due less VOC emissions, lesser exposure to hazardous air pollutants, stringent environmental regulations and introduction of technology toward eco-friendly products.

Asia is the major consumer of construction bio-based repaints and generates huge revenues in this market. It was observed that there is an increased demand for construction repaints in Asian countries such as Japan, China, and India. This is due to the developing economies, evolution in construction industry, rebuilding aged buildings, rise in infrastructure repairs, and increased use of waterborne coatings in paints. The increase in consumption of construction repaints due to increasing population, modernization and industrialization will drive the construction repaints market in Asia over the next few years.

To know more, click on the link below:

https://www.kenresearch.com/metal-mining-and-chemicals/chemicals/asia-construction-repaint-industry-situation-and-prospects-research-report/145754-101.html

Related Reports:

https://www.kenresearch.com/metal-mining-and-chemicals/chemicals/china-construction-repaint-industry-situation-and-prospects-research-report/146264-101.html

https://www.kenresearch.com/metal-mining-and-chemicals/chemicals/global-construction-repaint-industry-situation-and-prospects-research-report/146096-101.html

Contact Us:

Ken Research

Ankur Gupta, Head Marketing & Communications

sales@kenresearch.com

0124-4230204

New Clinical Trials For Treatment Of Hypothryroidism: Ken Research

According to the study, ‘HYPOTHYROIDISM GLOBAL CLINICAL TRIALS REVIEW, H1, 2018’, the major organizations conducting clinical trials in the treatment of hypothyroidism include IBSA Institut Biochimique SA, Mylan NV, PRACS Institute, Ltd., Akrimax Pharmaceuticals LLC, Vale Pharmaceuticals Ltd, Uni-Pharma SA, Teva Pharmaceutical Industries Ltd, Takeda Pharmaceutical Co Ltd, Ipe LLC, Dompe Farmaceutici SpA. Scientists from Rush University Medical Center have recently gained new knowledge on hypothyroidism. This condition affects humungous population alone in the United States. The study involved rats whose thyroid gland was removed. The study aimed at knowing why circulating different levels of T4 alone does not correct all the symptoms in all the patients. The study revealed that the patients that had received T4 alone had higher cholesterol as compared to the subjects that received combination of T4 and T3. These subjects also showed signs of hypothyroidism in brain which could one of the possible explanations of the ‘foggy brain’ symptom that is experienced by hypothyroid patients.

Hypothyroidism is a situation when the body of an individual is not able to produce adequate thyroid hormones. Thyroid is a gland that is present at the front of an individual’s neck that releases hormones which allow regulation of usage of energy. The thyroid is responsible for providing energy to all organs in a person’s body. It regulates how the heart beats or how the digestive system functions. If the thyroid does not produce adequate hormones then normal life processes begin to slow down. For nearly a century, natural thyroid preparations are used to treat hypothyroidism which contains thyroxine and triiodothyronine. The dosage of this treatment was adjusted according to the severity of the condition. The standard treatment involved using T4 supplements on a daily basis which later converted to T3 within the body. However a small percentage of population affected by this condition is not relieved of all the symptoms. The scientists suggest that this could probably be due to the subjectivity as to how people feel. Many people feel symptoms of this condition due to post menopause syndrome or clinical depression.

A new study conducted on large population by the University of Groningen in Netherland reveals that the people who consume thyroid replacement hormone, Levothyroxine may have more co morbidities and lower quality of life as compared to those who do not consume the hormone. The presence of co morbidities was witnessed to have a more negative impact on the quality of life of T4 users. Keeping in mind this research, scientists are conducting research to improve the condition of hypothyroid along with working to enhance the quality of life.

The condition of hypothyroidism is very common throughout the world without a known 100 percent successful treatment. Companies and institutions are pursuing clinical trials in order to achieve a successful treatment and gain the first mover advantage. Considering this condition is extremely common, the growth potential that lies in this industry is immense. Companies shall need to realize this potential in order to tap the untapped market.

To know more, click on the link below:

https://www.kenresearch.com/healthcare/general-healthcare/hypothyroidism-global-clinical/150989-91.html

Related Reports

https://www.kenresearch.com/healthcare/general-healthcare/hypothyroidism/31850-91.html

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
sales@kenresearch.com

+91-9015378249

Global Heart Valve Industry, Types, Users, Trends: Ken Research

According to the study, ‘Prosthetic Heart Valves - Medical Devices Pipeline Assessment, 2018’, some major companies and institutions manufacturing prosthetic heart valves are Abbott Vascular Inc, Boston Scientific Corp, HLT, Inc., Medtronic plc, Polyvascular Corp to name a few. By end user segmentation, there are no clear guidelines regarding usage of mechanical or biological vales. The prime advantage of biological valves is that they do not require treatment with war faring but some problems might emerge after 5-7 years of usage. There are no primary failures concerning mechanical valves however they require anticoagulation to prevent thrombosis and thromboembolism which makes the patient susceptible to bleeding. It is because of these reasons that surgeons prefer to use mechanical valves in age less than 60 years and biological valve in people more than 60 years of age. Due to recent developments in biological valves, there is a trend especially in the United Kingdom to use these biological valves in younger patients.

The human heart can be considered as a displacement pump working every day of an individual’s life to support the blood circulation in the body. The heart is a twin pumping mechanism divided into 2 parts each. One aimed at receiving the blood from the veins and the other to pump out the blood via the arteries. One of these valves can be damaged due to reasons such as injury or by birth. Repair of the damaged valve involves a complete replacement with a device referred to as the prosthetic heart valve. The first prosthetic heart valve was invented in 1952 when a Plexiglas cage containing a ball occlude was inserted into the descending thoracic area. Later, many improvements came along in the device that claimed to improve the design and overall efficiency of the device. There are primarily two types of replacement valves. These are mechanical valves and biological valves. Biological valves are made from tissue of living being especially animal tissue whereas mechanical valves are manufactured from chemical and industrial materials. A new type of valve was developed beginning of the 21^st century that is referred to as the Transcatheter valves. These consist of biological tissue mounted within an expandable stent.

The needs of the world are set to change rapidly. Currently a vast percentage of population that undergoes open heart procedures is conducted in countries representing a very small portion of the total population. As developing countries increase their per capita funds, the number of young patients suffering from rheumatic diseases will increase. Also, as the population of the developed countries begins to age the degenerative diseases will catch up. These trends shall shift the research into new variants of valves which would be characterized by physiological function, durability and not require warfarin. New Research is being conducted to develop biochemical valves and also, new oral coagulants are being developed which could make the mechanical valves safe and effective.

Huge potential lies in the heart valve industry and is expecting to see a strong growth rate in the future due to increasing awareness and financial capability of individuals all around the globe.

For More Information, Refer to the Link below:-

https://www.kenresearch.com/healthcare/medical-devices/prosthetic-heart-valves/151030-91.html

Related Reports:

https://www.kenresearch.com/healthcare/medical-devices/mexico-prosthetic-heart-valves-market-outlook-to-2025/149388-91.html

https://www.kenresearch.com/healthcare/medical-devices/australia-prosthetic-heart-valves-market-outlook-to-2025/149386-91.html

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
Sales@kenresearch.com
+91-9015378249